secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ensysce Biosciences, Inc. (ENSC)
CIK:        0001716947
Form:       8-K
Filed at:   2023-02-07T23:59:59+00:00
Accession:  0001493152-23-003873
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 3.03, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ensysce Biosciences closes $3.0M registered direct offering of 3.57M shares at $0.84/share
--------------------------------------------------------------------------------

- Gross proceeds of $3.0M from sale of 3,571,431 common shares at $0.84 per share in registered direct offering.
- Concurrent private placement: warrants to purchase up to 3,571,431 shares at $0.715, exercisable for 5.5 years.
- Board increased authorized Series A Preferred shares to pay stock dividend of 0.001 share per common share; record date Feb 13, 2023.
- H.C. Wainwright acted as placement agent; received 7% cash fee and warrants to buy 250,000 shares at $1.05.
- Company has 30-day lockup; officers and directors have 90-day lockup on further equity sales.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716947/000149315223003873/0001493152-23-003873-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716947/000149315223003873/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-003873

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer